Literature DB >> 25326578

Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension.

Eva Nozik-Grayck1, Crystal Woods2, Joann M Taylor3, Richard K P Benninger4, Richard D Johnson2, Leah R Villegas5, Kurt R Stenmark5, David G Harrison6, Susan M Majka6, David Irwin7, Kathryn N Farrow3.   

Abstract

Excess superoxide has been implicated in pulmonary hypertension (PH). We previously found lung overexpression of the antioxidant extracellular superoxide dismutase (EC-SOD) attenuates PH and pulmonary artery (PA) remodeling. Although comprising a small fraction of total SOD activity in most tissues, EC-SOD is abundant in arteries. We hypothesize that the selective loss of vascular EC-SOD promotes hypoxia-induced PH through redox-sensitive signaling pathways. EC-SOD(loxp/loxp) × Tg(cre/SMMHC) mice (SMC EC-SOD KO) received tamoxifen to conditionally deplete smooth muscle cell (SMC)-derived EC-SOD. Mice were exposed to hypobaric hypoxia for 35 days, and PH was assessed by right ventricular systolic pressure measurements and right ventricle hypertrophy. Vascular remodeling was evaluated by morphometric analysis and two-photon microscopy for collagen. We examined cGMP content and soluble guanylate cyclase expression and activity in lung, lung phosphodiesterase 5 (PDE5) expression and activity, and expression of endothelial nitric oxide synthase and GTP cyclohydrolase-1 (GTPCH-1), the rate-limiting enzyme in tetrahydrobiopterin synthesis. Knockout of SMC EC-SOD selectively decreased PA EC-SOD without altering total lung EC-SOD. PH and vascular remodeling induced by chronic hypoxia was augmented in SMC EC-SOD KO. Depletion of SMC EC-SOD did not impact content or activity of lung soluble guanylate cyclase or PDE5, yet it blunted the hypoxia-induced increase in cGMP. Although total eNOS was not altered, active eNOS and GTPCH-1 decreased with hypoxia only in SMC EC-SOD KO. We conclude that the localized loss of PA EC-SOD augments chronic hypoxic PH. In addition to oxidative inactivation of NO, deletion of EC-SOD seems to reduce eNOS activity, further compromising pulmonary vascular function.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  endothelial nitric oxide synthase; extracellular superoxide dismutase; guanosine 3′,5′-cyclic monophosphate; guanylate cyclase; hypoxia; nitric oxide synthase; phosphodiesterase; pulmonary vascular remodeling

Mesh:

Substances:

Year:  2014        PMID: 25326578      PMCID: PMC4254965          DOI: 10.1152/ajplung.00096.2014

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  35 in total

Review 1.  Extracellular superoxide dismutase: a regulator of nitric oxide bioavailability.

Authors:  T D Oury; B J Day; J D Crapo
Journal:  Lab Invest       Date:  1996-11       Impact factor: 5.662

Review 2.  Emerging therapies for the treatment of pulmonary hypertension.

Authors:  Kurt R Stenmark; Marlene Rabinovitch
Journal:  Pediatr Crit Care Med       Date:  2010-03       Impact factor: 3.624

3.  Hypoxia reduces atrial natriuretic peptide clearance receptor gene expression in ANP knockout mice.

Authors:  J Z Sun; S J Chen; G Li; Y F Chen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-09       Impact factor: 5.464

4.  Multimodal CARS microscopy determination of the impact of diet on macrophage infiltration and lipid accumulation on plaque formation in ApoE-deficient mice.

Authors:  Ryan S Lim; Adelheid Kratzer; Nicholas P Barry; Shinobu Miyazaki-Anzai; Makoto Miyazaki; William W Mantulin; Moshe Levi; Eric O Potma; Bruce J Tromberg
Journal:  J Lipid Res       Date:  2010-03-05       Impact factor: 5.922

Review 5.  Reactive oxygen species as therapeutic targets in pulmonary hypertension.

Authors:  Véronique Freund-Michel; Christelle Guibert; Mathilde Dubois; Arnaud Courtois; Roger Marthan; Jean-Pierre Savineau; Bernard Muller
Journal:  Ther Adv Respir Dis       Date:  2013-01-17       Impact factor: 4.031

6.  Increased p22(phox)/Nox4 expression is involved in remodeling through hydrogen peroxide signaling in experimental persistent pulmonary hypertension of the newborn.

Authors:  Stephen Wedgwood; Satyan Lakshminrusimha; Lyubov Czech; Paul T Schumacker; Robin H Steinhorn
Journal:  Antioxid Redox Signal       Date:  2013-02-15       Impact factor: 8.401

7.  Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertension.

Authors:  Kathryn N Farrow; Satyan Lakshminrusimha; William J Reda; Stephen Wedgwood; Lyubov Czech; Sylvia F Gugino; Jonathan M Davis; James A Russell; Robin H Steinhorn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-09-12       Impact factor: 5.464

8.  Lung EC-SOD overexpression attenuates hypoxic induction of Egr-1 and chronic hypoxic pulmonary vascular remodeling.

Authors:  Eva Nozik-Grayck; Hagir B Suliman; Susan Majka; Joseph Albietz; Zachary Van Rheen; Kevin Roush; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-07-03       Impact factor: 5.464

Review 9.  Cellular and molecular basis of pulmonary arterial hypertension.

Authors:  Nicholas W Morrell; Serge Adnot; Stephen L Archer; Jocelyn Dupuis; Peter Lloyd Jones; Margaret R MacLean; Ivan F McMurtry; Kurt R Stenmark; Patricia A Thistlethwaite; Norbert Weissmann; Jason X-J Yuan; E Kenneth Weir
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

10.  Xanthine oxidase-derived ROS upregulate Egr-1 via ERK1/2 in PA smooth muscle cells; model to test impact of extracellular ROS in chronic hypoxia.

Authors:  Tanya Hartney; Rahul Birari; Sujatha Venkataraman; Leah Villegas; Maylyn Martinez; Stephen M Black; Kurt R Stenmark; Eva Nozik-Grayck
Journal:  PLoS One       Date:  2011-11-28       Impact factor: 3.240

View more
  26 in total

1.  Redox Biology of Peroxisome Proliferator-Activated Receptor-γ in Pulmonary Hypertension.

Authors:  Victor Tseng; Roy L Sutliff; C Michael Hart
Journal:  Antioxid Redox Signal       Date:  2019-02-25       Impact factor: 8.401

Review 2.  Nitric Oxide and Hydrogen Sulfide Regulation of Ischemic Vascular Growth and Remodeling.

Authors:  Saranya Rajendran; Xinggui Shen; John Glawe; Gopi K Kolluru; Christopher G Kevil
Journal:  Compr Physiol       Date:  2019-06-12       Impact factor: 9.090

3.  Exogenous NAD(+) administration significantly protects against myocardial ischemia/reperfusion injury in rat model.

Authors:  Youjun Zhang; Ban Wang; Xingli Fu; Shaofeng Guan; Wenzheng Han; Jie Zhang; Qian Gan; Weiyi Fang; Weihai Ying; Xinkai Qu
Journal:  Am J Transl Res       Date:  2016-08-15       Impact factor: 4.060

4.  Histone deacetylation contributes to low extracellular superoxide dismutase expression in human idiopathic pulmonary arterial hypertension.

Authors:  Eva Nozik-Grayck; Crystal Woods; Robert S Stearman; Sujatha Venkataraman; Bradley S Ferguson; Kalin Swain; Russell P Bowler; Mark W Geraci; Kaori Ihida-Stansbury; Kurt R Stenmark; Timothy A McKinsey; Frederick E Domann
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-05-27       Impact factor: 5.464

Review 5.  Update on novel targets and potential treatment avenues in pulmonary hypertension.

Authors:  John C Huetsch; Karthik Suresh; Meghan Bernier; Larissa A Shimoda
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-02       Impact factor: 5.464

6.  Intermittent normobaric hypoxia facilitates high altitude acclimatization by curtailing hypoxia-induced inflammation and dyslipidemia.

Authors:  Anamika Gangwar; Manish Sharma; Krishan Singh; Anita Patyal; Gopinath Bhaumik; Kalpana Bhargava; Niroj Kumar Sethy
Journal:  Pflugers Arch       Date:  2019-04-13       Impact factor: 3.657

7.  Cocktail of Superoxide Dismutase and Fasudil Encapsulated in Targeted Liposomes Slows PAH Progression at a Reduced Dosing Frequency.

Authors:  Nilesh Gupta; Jahidur Rashid; Eva Nozik-Grayck; Ivan F McMurtry; Kurt R Stenmark; Fakhrul Ahsan
Journal:  Mol Pharm       Date:  2017-02-17       Impact factor: 4.939

8.  Superoxide Dismutase 3 R213G Single-Nucleotide Polymorphism Blocks Murine Bleomycin-Induced Fibrosis and Promotes Resolution of Inflammation.

Authors:  Gary C Mouradian; Rohit Gaurav; Steve Pugliese; Karim El Kasmi; Brittany Hartman; Laura Hernandez-Lagunas; Kurt R Stenmark; Russell P Bowler; Eva Nozik-Grayck
Journal:  Am J Respir Cell Mol Biol       Date:  2017-03       Impact factor: 6.914

9.  Genetic ablation of interleukin-18 does not attenuate hypobaric hypoxia-induced right ventricular hypertrophy.

Authors:  Danielle R Bruns; Peter M Buttrick; Lori A Walker
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-01-08       Impact factor: 5.464

10.  R213G polymorphism in SOD3 protects against bleomycin-induced inflammation and attenuates induction of proinflammatory pathways.

Authors:  Anastacia M Garcia; Ayed Allawzi; Philip Tatman; Laura Hernandez-Lagunas; Kalin Swain; Gary Mouradian; Russell Bowler; Anis Karimpour-Fard; Carmen C Sucharov; Eva Nozik-Grayck
Journal:  Physiol Genomics       Date:  2018-07-13       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.